Back to Search
Start Over
Policy Recommendations for Pharmacy Benefit Managers to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians.
- Source :
-
Annals of internal medicine [Ann Intern Med] 2019 Dec 03; Vol. 171 (11), pp. 823-824. Date of Electronic Publication: 2019 Nov 12. - Publication Year :
- 2019
-
Abstract
- Recent discussions about the increasing prices of prescription drugs have focused on pharmacy benefit managers (PBMs), third-party intermediaries for various types of employers and government purchasers who negotiate drug prices in health plans and thus play a crucial role in determining the amount millions of Americans pay for medications. In this position paper, the American College of Physicians expands on its position paper from 2016 by offering additional recommendations to improve transparency in the PBM industry and highlighting the need for reliable, timely, and relevant information on prescription drug pricing for physicians and patients.
- Subjects :
- Cost Savings
Drug Costs legislation & jurisprudence
Drug Industry economics
Humans
Insurance, Pharmaceutical Services legislation & jurisprudence
Pharmaceutical Services economics
Pharmaceutical Services legislation & jurisprudence
Prescription Drugs classification
United States
Insurance, Pharmaceutical Services economics
Prescription Drugs economics
Subjects
Details
- Language :
- English
- ISSN :
- 1539-3704
- Volume :
- 171
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Annals of internal medicine
- Publication Type :
- Academic Journal
- Accession number :
- 31711103
- Full Text :
- https://doi.org/10.7326/M19-0035